Company

Presidio Medical, Inc.

Presidio Medical develops neuromodulation therapy for chronic pain with its Ultra Low Frequency (ULF) system.

About

Founded in 2017 and headquartered in San Francisco, US, Presidio Medical, Inc. sells its ULF Neuromodulation System to hospitals and medical facilities. Kenneth Wu is the founder and Michael Onuscheck is CEO. In June 2023 the company raised USD 72.00 mn in Series C funding led by Deerfield Management Company, with ShangBay Capital, Action Potential Venture Capital and Invus participating. The funds will support clinical trials of the ULF SCS system and expanded production.

2Funding rounds

4Investors

Sign in to see more

Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.

Sign in